ChIP assays confirmed that binding of MYCN could be detected in the MYCN-amplified neuroblastoma cell lines NB19 and LA-N-1, whereas it was absent in the non-MYCN-amplified SHSY5Y cell line (Fig. 4A). This evidence concerns the gene MYCN and neuroblastoma.